Welcome!

Our lab studies the contribution of genetic and epigenetic variation to aberrant gene expression in B cell malignancies. We use an integrated systems biology approach to study genome-wide methylation, gene expression and DNA sequence variation to understand pathogenesis, develop biomarkers and guide personalized therapy in B cell malignancies, particularly non-Hodgkins Lymphoma and Multiple Myeloma.